Navigation Links
Anti-biotech groups obstruct forest biotechnology
Date:6/30/2009

CORVALLIS, Ore. The potential of forest biotechnology to help address significant social and environmental issues is being "strangled at birth" by the rigid opposition of some groups and regulations that effectively preclude even the testing of genetically modified trees, scientists argue in a new report.

Steps must be taken to create a regulatory environment that considers genetically modified trees on a scientific, case-by-case basis, and is focused on the end product rather than the process, say researchers from Oregon State University, Carnegie Mellon University and other institutions in an article in the journal Nature Biotechnology.

Lacking that, the potential will be lost to use this powerful tool to create trees that grow faster, better resist drought or disease, restore threatened species, reduce costs, contribute to renewable energy, sequester carbon, improve environmental cleanup, and produce badly needed products for global consumers, the scientists said.

"This is a noose that's been slowly tightening for many years," said Steven Strauss, a distinguished professor of forest biotechnology at OSU, and one of the world's leaders in the application of genetic science to forestry.

"Everyone wants safe and responsible regulations that protect the environment," Strauss said. "But some extreme opponents who see anything that is genetically modified as a mortal sin are successfully putting in place details that will make it virtually impossible to move ahead with genetic modification in forestry or woody energy crops.

"They don't even want to see field research," Strauss said, "which is required for analysis of ecological effects as well as benefits, and they have been making strides toward shutting the industry down."

Some major successes with biotechnology have taken place in crop agriculture, Strauss said, and because of the enormous benefits, that industry has learned to wade through the regul
'/>"/>

Contact: Steven Strauss
steve.strauss@oregonstate.edu
541-760-7357
Oregon State University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Business, scientific, higher education groups laud President Obamas commitment to science
2. Disabled and other vulnerable groups more susceptible to terrorism fears
3. Caltech researchers get first look at how groups of cells coordinate their movements
4. Gender biases in leadership selection during competitions within and between groups
5. Nations and conservation groups seek plan to protect Ghost of the Himalayas
6. Madagascars tortoises are crawling toward extinction, groups say
7. Environmental groups call for increased protection of coral reefs
8. Varying prevalence among ethnic groups of gene mutation that increases risk of breast cancer
9. Tree of life for flowering plants reveals relationships among major groups
10. UF botanists: Flowering plants evolved very quickly into 5 groups
11. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...an has received more than $10 million in research ...ederal stimulus program, bringing thetotal amount ...$23 million. Thirty-three projects achieved stimu...o weather. , "The university has thoughtfully un... scholarly excellence to federal agency priorities...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
(Date:11/4/2009)...wswire/ -- GenVault Corporation (Carlsbad, CA) tod...joined its Board of Directors. Dr. Brody, the Irw..., is an acclaimed physician-scientist and universi...r. Brody served as president of The Johns Hopkins ...y of Engineering and the Institute of Medicine, an...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Hormone therapy may confer more aggressive properties to prostate tumors 48453 1Drugs against winter vomiting disease one step closer 48451 1Drugs against winter vomiting disease one step closer 48451 2New Jefferson study may redefine how a chronic auto immune disease is diagnosed 48449 1New Jefferson study may redefine how a chronic auto immune disease is diagnosed 48449 2
...A - GEOLOGY topics span the globe and beyond, co...stones and shales of Scotland, a "Greenhouse World... Greenland, oxidation of methane in southern Namib..., gold nanoparticles in Australia, and the possibi...SA TODAY contains the first authoritative geologi...
...June 20, 2008) The future of high-intensity x-ray...ts at U.S. Department of Energy,s Argonne National...tion light sources. , "The free electron laser os...ys up to one hundred million times brighter than c...d fellow Kwang-Je Kim said. , Current technology ...
... by a scientist from The University of Western Ont...ecades-old evolutionary doctrines long accepted as...d Dawkins ("The God Delusion") introduced the conc...world over have hailed the theory as a natural ext...ing genomes, the word ,selfish, does not refer to ...
Other Biology News:July 2008 GEOLOGY and GSA Today media highlights 2July 2008 GEOLOGY and GSA Today media highlights 3July 2008 GEOLOGY and GSA Today media highlights 4July 2008 GEOLOGY and GSA Today media highlights 5July 2008 GEOLOGY and GSA Today media highlights 6July 2008 GEOLOGY and GSA Today media highlights 7July 2008 GEOLOGY and GSA Today media highlights 8A novel X-ray source could be brightest in the world 2
(Date:11/4/2009)...ch will be presented on November 19 and is of inte...y processing, will deal with the application of th...micro scale flow chemistry equipment. Professor L...ized with several prestigious prizes and awards, i... , Columbia, MD (PRWEB) N...
(Date:11/4/2009)...irstCall/ -- Star Scientific, Inc . (Nasdaq: S...troduce the CigRx(TM) nutraceutical product develo... for worldwide marketing and sales in partnership ...Ventiv Health offers a complete range of commercia...lifecycle, in a range of healthcare categories tha...
(Date:11/4/2009)...e-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR...ird quarter ended September 30, 2009. ,, Net l...ved to $31.0 million or $0.33 per share, as compar...re in the third quarter of 2008. ,, Nektar c...iciencies as compared to a year ago. Total operat...
(Date:11/4/2009)...ire/ -- Health Robotics today announced,the worldw...rkflow Engine at,the American Society of Health-Sy...n Las Vegas. With the availability of the i.v.SOFT...t and only company in the world to provide a,total... process control and,patient safety in the I.V. Ro...
Breaking Biology Technology:Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas 2Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas 3
...up, Inc. (MED3OOO), a,national healthcare manageme...sultants, Inc. of Michigan City, IN, recently sele...OOO -- for billing, marketing, and business,suppor...nty-physician pathology practice,providing service...ers and,seven hospitals located in northwest India...
...nc. (BCI), a,biopharmaceutical company utilizing i...pounds that promote the growth of new neurons for ...ases, announced today that it raised an,additional...cing, bringing,the total to $50 million. New inves...rrent investors and Alexandria Real Estate Equitie...
... April 17 ,InforMedix Holdings, Inc. (OTC Bulletin...tor(TM), and Med-eXpert(TM) Systems to improve,med...d InnovationRx, a,provider of prescription medicat... market and sell a combined product line to a broa...ies, insurance companies, health plans,managed car...
Other Biology Technology:Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner 2Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner 3BrainCells Inc. Expands Series B Financing to $50 Million 2InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions 2InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions 3InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions 4InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions 5
Mouse Anti-Human E1A (adenovirus early region 1) Monoclonal Antibody, Unconjugated, Clone M73 from Exalpha Biologicals, Inc.
Blocking Reagent, TBS with 1% BSA from Bethyl Laboratories
Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON
RayBio Human Chemokine Antibody Array I & 1.1 Service from Raybiotech, Inc.
Biology Products: